|
|
Other links at Articles > Diabetes and Endocrinology |
| 1. |
FDA Approvals: Glumetza, Nexavar, Micera
|
|
|
The FDA has approved a new strength for metformin HCl extended-release tablets, a new indication for sorafenib tosylate tablets, and methoxy polyethylene glycol-epoetin beta. Medscape Medical News
|
| 2. |
International Approvals: Oral-lyn, Abraxane, DepoDur
|
|
|
India has approved a regular insulin oral spray (Oral-lyn) and albumin-bound paclitaxel particles for injectable suspension (Abraxane); Australia has approved a sustained-release liposome formulation of morphine sulfate injection (DepoDur). Medscape Medical News
|
| 5. |
Cromolyn May Reverse Insulin Analog-Induced Lipoatrophy
|
|
|
Mast cell stabilizing therapy with topical cromolyn can reverse early injection-site lipoatrophy induced by human insulin analogs, and prevent further lesions, according to a report in the March issue of Diabetes Care. Reuters Health Information
|
|
|